Amplitude Surgical SAS (AMPLI) - Net Assets
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has net assets worth €94.70 Million EUR (≈ $110.71 Million USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€279.66 Million ≈ $326.96 Million USD) and total liabilities (€184.97 Million ≈ $216.25 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Amplitude Surgical SAS tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €94.70 Million |
| % of Total Assets | 33.86% |
| Annual Growth Rate | 10.75% |
| 5-Year Change | 35.12% |
| 10-Year Change | -19.31% |
| Growth Volatility | 117.97 |
Amplitude Surgical SAS - Net Assets Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's net assets have evolved over time, based on quarterly financial data. See AMPLI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Amplitude Surgical SAS (2011–2024)
The table below shows the annual net assets of Amplitude Surgical SAS from 2011 to 2024. For live valuation and market cap data, see AMPLI stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | €95.82 Million ≈ $112.02 Million |
+0.01% |
| 2023-06-30 | €95.81 Million ≈ $112.02 Million |
+82.26% |
| 2022-06-30 | €52.57 Million ≈ $61.46 Million |
-7.56% |
| 2021-06-30 | €56.87 Million ≈ $66.48 Million |
-19.81% |
| 2020-06-30 | €70.91 Million ≈ $82.90 Million |
-17.06% |
| 2019-06-30 | €85.50 Million ≈ $99.95 Million |
-9.70% |
| 2018-06-30 | €94.68 Million ≈ $110.69 Million |
-8.20% |
| 2017-06-30 | €103.14 Million ≈ $120.58 Million |
-12.68% |
| 2016-06-30 | €118.12 Million ≈ $138.09 Million |
-0.54% |
| 2015-06-30 | €118.76 Million ≈ $138.84 Million |
+432.28% |
| 2014-06-30 | €22.31 Million ≈ $26.08 Million |
+9.16% |
| 2013-06-30 | €20.44 Million ≈ $23.89 Million |
-8.74% |
| 2012-06-30 | €22.40 Million ≈ $26.18 Million |
-11.81% |
| 2011-06-30 | €25.40 Million ≈ $29.69 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Amplitude Surgical SAS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 379400000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.53 Million | 1.59% |
| Common Stock | €480.00K | 0.50% |
| Other Comprehensive Income | €-52.86 Million | -55.17% |
| Other Components | €146.68 Million | 153.07% |
| Total Equity | €95.82 Million | 100.00% |
Amplitude Surgical SAS Competitors by Market Cap
The table below lists competitors of Amplitude Surgical SAS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
908 Devices Inc
NASDAQ:MASS
|
$299.86 Million |
|
P-Duke Technology Co Ltd
TWO:8109
|
$299.95 Million |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
$300.00 Million |
|
NACCO Industries Inc
NYSE:NC
|
$300.08 Million |
|
Compucase Enterprise Co Ltd
TW:3032
|
$299.81 Million |
|
Shandong Sinoglory Health
SHG:603182
|
$299.78 Million |
|
Oceania Healthcare Ltd
AU:OCA
|
$299.78 Million |
|
Arvind SmartSpaces Limited
NSE:ARVSMART
|
$299.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amplitude Surgical SAS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 95,813,000 to 95,821,000, a change of 8,000 (0.0%).
- Net income of 1,528,000 contributed positively to equity growth.
- Share repurchases of 59,000 reduced equity.
- Other comprehensive income increased equity by 37,726,000.
- Other factors decreased equity by 39,187,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.53 Million | +1.59% |
| Share Repurchases | €59.00K | -0.06% |
| Other Comprehensive Income | €37.73 Million | +39.37% |
| Other Changes | €-39.19 Million | -40.9% |
| Total Change | €- | 0.01% |
Book Value vs Market Value Analysis
This analysis compares Amplitude Surgical SAS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.13x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.85x to 3.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-06-30 | €0.80 | €6.25 | x |
| 2012-06-30 | €0.70 | €6.25 | x |
| 2013-06-30 | €0.64 | €6.25 | x |
| 2014-06-30 | €0.70 | €6.25 | x |
| 2015-06-30 | €2.53 | €6.25 | x |
| 2016-06-30 | €2.51 | €6.25 | x |
| 2017-06-30 | €2.21 | €6.25 | x |
| 2018-06-30 | €2.04 | €6.25 | x |
| 2019-06-30 | €1.82 | €6.25 | x |
| 2020-06-30 | €1.52 | €6.25 | x |
| 2021-06-30 | €1.23 | €6.25 | x |
| 2022-06-30 | €1.13 | €6.25 | x |
| 2023-06-30 | €2.00 | €6.25 | x |
| 2024-06-30 | €2.00 | €6.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amplitude Surgical SAS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.44%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 2.91x
- Recent ROE (1.59%) is above the historical average (-6.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -8.92% | 0.00% | 0.00x | 4.92x | €-4.81 Million |
| 2012 | -9.01% | -4.27% | 0.36x | 5.82x | €-4.26 Million |
| 2013 | -10.51% | -4.28% | 0.36x | 6.91x | €-4.19 Million |
| 2014 | -12.79% | -4.89% | 0.33x | 7.86x | €-5.07 Million |
| 2015 | -14.86% | -24.82% | 0.29x | 2.08x | €-29.52 Million |
| 2016 | 0.19% | 0.27% | 0.31x | 2.18x | €-11.57 Million |
| 2017 | -11.64% | -12.91% | 0.34x | 2.62x | €-22.41 Million |
| 2018 | -9.88% | -9.41% | 0.35x | 3.01x | €-19.01 Million |
| 2019 | -10.35% | -8.76% | 0.37x | 3.22x | €-17.68 Million |
| 2020 | -19.58% | -16.08% | 0.32x | 3.80x | €-21.45 Million |
| 2021 | -23.93% | -17.05% | 0.31x | 4.57x | €-19.99 Million |
| 2022 | -8.11% | -5.02% | 0.34x | 4.79x | €-9.81 Million |
| 2023 | 40.96% | 39.17% | 0.38x | 2.78x | €29.66 Million |
| 2024 | 1.59% | 1.44% | 0.38x | 2.91x | €-8.05 Million |
Industry Comparison
This section compares Amplitude Surgical SAS's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $194,190,725
- Average return on equity (ROE) among peers: -164.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amplitude Surgical SAS (AMPLI) | €94.70 Million | -8.92% | 1.95x | $299.85 Million |
| Crossject (ALCJ) | $947.65K | -192.33% | 4.96x | $101.91 Million |
| I.Ceram SA (ALICR) | $39.31K | -1004.66% | 81.41x | $155.73K |
| Safe Orthopaedics SA (ALSAF) | $-4.28 Million | 0.00% | 0.00x | $118.65K |
| Spineway (ALSPW) | $4.62 Million | -36.05% | 1.43x | $4.57 Million |
| Sartorius Stedim Biotech SA (DIM) | $148.35 Million | 14.85% | 1.44x | $15.98 Billion |
| EssilorLuxottica S. A. (EL) | $1.21 Billion | 13.57% | 0.78x | $99.36 Billion |
| Bonyf NV (MLBON) | $345.47K | 55.19% | 3.01x | $2.48 Million |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more